Restart Life Sciences Corp. (CSE:HEAL)

Restart Life Sciences Revenue

Restart Life Sciences had revenue of 134.55K CAD in the quarter ending March 31, 2026. This brings the company's revenue in the last twelve months to 134.55K.

• Revenue (ttm): 134.55K
• Revenue Growth: n/a
• P/S Ratio: 38.58
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 5.19M

Revenue Chart

Chart

Chart

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	-	-	-
Dec 31, 2024	-	-	-
Dec 31, 2023	-	-	-
Dec 31, 2022	-	-	-
Dec 31, 2021	-	-	-

Data Source: S&P Global Market Intelligence Last updated: Mar 31, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Jul 21, 2026

Data Sources Report a data error